Literature DB >> 10558929

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.

J M Katz1, W Lim, C B Bridges, T Rowe, J Hu-Primmer, X Lu, R A Abernathy, M Clarke, L Conn, H Kwong, M Lee, G Au, Y Y Ho, K H Mak, N J Cox, K Fukuda.   

Abstract

The first documented outbreak of human respiratory disease caused by avian influenza A (H5N1) viruses occurred in Hong Kong in 1997. The kinetics of the antibody response to the avian virus in H5N1-infected persons was similar to that of a primary response to human influenza A viruses; serum neutralizing antibody was detected, in general, >/=14 days after symptom onset. Cohort studies were conducted to assess the risk of human-to-human transmission of the virus. By use of a combination of serologic assays, 6 of 51 household contacts, 1 of 26 tour group members, and none of 47 coworkers exposed to H5N1-infected persons were positive for H5 antibody. One H5 antibody-positive household contact, with no history of poultry exposure, provided evidence that human-to-human transmission of the avian virus may have occurred through close physical contact with H5N1-infected patients. In contrast, social exposure to case patients was not associated with H5N1 infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558929     DOI: 10.1086/315137

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  87 in total

1.  Influenza: New Insights Into an Old Disease.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

Review 2.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

3.  H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.

Authors:  Surender Khurana; Pretty Sasono; Annette Fox; Van Kinh Nguyen; Quynh Mai Le; Quang Thai Pham; Tran Hien Nguyen; Thanh Liem Nguyen; Peter Horby; Hana Golding
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Avian influenza - The next pandemic?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

5.  Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

6.  Ode to oseltamivir and amantadine?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-01       Impact factor: 2.471

7.  Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Nathaniel Hupert; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

Review 8.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Seroprevalence of antibodies to avian influenza virus A (H5N1) among residents of villages with human cases, Thailand, 2005.

Authors:  Rapeepan Dejpichai; Yongjua Laosiritaworn; Pilaipan Phuthavathana; Timothy M Uyeki; Michael O'Reilly; Nattaphon Yampikulsakul; Sumreung Phurahong; Phisanu Poorak; Jarunee Prasertsopon; Rumporn Kularb; Kannika Nateerom; Narumol Sawanpanyalert; Chuleeporn Jiraphongsa
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

10.  Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999.

Authors:  Timothy M Uyeki; Yu-Hoi Chong; Jacqueline M Katz; Wilina Lim; Yuk-Yin Ho; Sophia S Wang; Thomas H F Tsang; Winnie Wan-Yee Au; Shuk-Chi Chan; Thomas Rowe; Jean Hu-Primmer; Jensa C Bell; William W Thompson; Carolyn Buxton Bridges; Nancy J Cox; Kwok-Hang Mak; Keiji Fukuda
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.